This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Kimia Farma not implicated in unhealthy partnerships, Indonesian antitrust regulator says

( May 27, 2025, 02:19 GMT | Official Statement) -- MLex Summary: The Indonesian Competition Commission, or KPPU, said PT Kimia Farma Diagnostika, a subsidiary of the largest state-owned pharmaceutical company PT Kimia Farma Tbk, was not proven to have violated Law Number 20 of 2008 concerning the implementation of profit-sharing partnerships, which prohibits large businesses from controlling small- and medium-size companies in unhealthy partnership relationships. The case began with the regulator examining the cooperation agreement between PT Kimia Farma Diagnostika and partner doctors. The decision was released on Monday by the KPPU's Commission Panel.The KPPU statement, in Indonesian, follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections